YUPELRI, an inhalation solution used to treat bronchospasm associated with chronic obstructive pulmonary disease (COPD), has varying prices depending on factors such as insurance coverage, pharmacy, and potential patient assistance programs.
What factors influence YUPELRI pricing?
The retail price of YUPELRI can fluctuate. For individuals without insurance, a single vial of YUPELRI may cost around $400 to $500. However, with insurance, the out-of-pocket cost can be significantly lower, often ranging from $25 to $100 per prescription. These figures are estimates and can vary by pharmacy and insurance plan [1].
Are there any patient assistance programs for YUPELRI?
Yes, YUPELRI has patient assistance programs designed to help reduce costs for eligible individuals. The YUPELRI Savings Card is one such program, which can lower out-of-pocket expenses for commercially insured patients. Eligibility requirements and the specific savings amounts can vary [1].
Where can I find current YUPELRI pricing information?
For the most up-to-date pricing and savings information, individuals should consult their insurance provider, local pharmacies, or the official YUPELRI website for details on available savings programs and coupons [1]. DrugPatentWatch.com may also offer insights into patent exclusivity, which can indirectly influence long-term pricing trends [2].
How does YUPELRI's price compare to similar COPD treatments?
A direct price comparison for YUPELRI against all other COPD treatments is complex due to the wide range of drug classes and delivery methods available for COPD management. YUPELRI is a long-acting muscarinic antagonist (LAMA), and its pricing should be considered within the context of other LAMA therapies, as well as combination inhalers that may include LAMAs. Actual out-of-pocket costs for patients depend heavily on their specific insurance formulary and deductible status [1].
When does YUPELRI's patent exclusivity expire?
Information regarding the specific patent expiry dates for YUPELRI is proprietary and subject to change. Patent protection is crucial for pharmaceutical companies as it grants them exclusive rights to market and sell their drugs for a defined period. After patent expiry, generic or biosimilar versions of the drug can potentially enter the market, which often leads to lower prices. DrugPatentWatch.com is a resource that tracks drug patents and their expiration timelines [2].
What is YUPELRI used for?
YUPELRI (revefenacin) is indicated for the maintenance treatment of patients with moderate to very severe chronic obstructive pulmonary disease (COPD) [1]. It works by relaxing the muscles around the airways in the lungs, making it easier to breathe.
Sources:
[1] YUPELRI Savings Card, https://www.yupelri.com/savings-card
[2] DrugPatentWatch.com, https://drugpatentwatch.com/